ClinicalTrials.govpublic full text
Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas
non-functioning pituitary adenomas, prolactinomas, cabergoline, pasireotide, somatostatin receptors, dopamine receptors, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 894626
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.